InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: None

Saturday, 02/19/2022 1:22:34 AM

Saturday, February 19, 2022 1:22:34 AM

Post# of 425648
Something's rotten in the state of Denmark

---------------------------------------------------------
The Danish Medicines Agency has decided that Vazkepa, soft capsules containing icosapentethyl in the strength of 998 mg, should not have a general subsidy or a general conditional subsidy.

We assess that Vazkepa does not meet the criteria for general subsidies, including general conditional subsidies.

General reimbursement
When medicine receives a general reimbursement, it means that all patients receive an automatic reimbursement for the medicine in question when the medicine is bought on prescription at the pharmacy. The subsidy is automatically deducted from the price at the dispatch at the pharmacy. See the limits for medicine reimbursement here: medicine reimbursement limits

General conditional reimbursement
If a medicine has a general conditional reimbursement, this means that only patients who meet certain special conditions can receive a reimbursement for the medicine. It is the attending physician who assesses whether a patient is covered by the special conditions. In these cases, the doctor must write "Supplement" on the prescription. The subsidy is automatically deducted from the price at the dispatch at the pharmacy. See the limits for medicine reimbursement here: medicine reimbursement limits

https://laegemiddelstyrelsen-dk.translate.goog/da/nyheder/2022/vazkepa-faar-ikke-generelt-eller-generelt-klausuleret-tilskud/?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

https://www.investorvillage.com/uploads/87669/files/Vazkepa-Danish-decision.pdf


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News